(MedPage Today) -- The following contains links to social media websites including Bluesky, X, TikTok, Instagram, Facebook, and LinkedIn. Is that a night shift nurse or a ghost? Intensive care unit nurse Blake Lynch, RN, got in the spooky spirit...
(MedPage Today) -- Open enrollment for Medicare plans begins Thursday and enrollees will face a slew of changes that go into effect in 2027. During the enrollment period, which ends Dec. 7, people will have the opportunity to choose between…
(MedPage Today) -- Rates of amyloid-related imaging abnormalities (ARIA) in Alzheimer's disease patients treated with lecanemab (Leqembi) in the real world were consistent with those seen in clinical trials, data from the LEADER study showed....
(MedPage Today) -- For medium vessel occlusion strokes, perfusion mismatch ratio predicted follow-up infarct volume, a multinational trial showed, supporting a role similar to that in large vessel occlusion. In the 94 isolated M2-segment occlusion...
It’s Zocdoc’s first acquisition in its nearly 20-year history as the online medical scheduling company works to scale its business. Sohar already provides insurance eligibility checks within Zocdoc’s appointment scheduling platform.
(MedPage Today) -- For the first time in more than a quarter-century, Americans have a new option when shopping for sunscreen: a skin-protecting chemical that's long been a go-to option in Europe and other parts of the world. The FDA…
(MedPage Today) -- Researchers found that late-night eating -- after dinner or bedtime -- was associated with a 28% increased risk for liver cirrhosis and a 36% higher risk for metabolic dysfunction-associated steatotic liver disease (MASLD...
(MedPage Today) -- Note that some links may require registration or subscription. A 2022 paper that found COVID-19 vaccination elicits broad neutralizing antibodies in mice was retracted by Science Translational Medicine for some fabricated data...
(MedPage Today) -- PHOENIX -- Cardiovascular inflammation was highly prevalent among U.S. heart failure (HF) patients, a registry study found, illustrating the unmet need for good inflammation-targeting pharmacotherapy. In a subanalysis of POSEIDON...